Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules

A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia

(2012) Vincenzo Serretta et al.   Clinical Genitourinary Cancer

Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects

(2011) N. Pemmaraju et al.   ANNALS OF ONCOLOGY

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

(2010) Daniel C. Danila et al.   JOURNAL OF CLINICAL ONCOLOGY

Is Prophylactic Breast Radiotherapy Necessary in All Patients With Prostate Cancer and Gynecomastia and/or Breast Pain?

(2010) Haluk Ozen et al.   JOURNAL OF UROLOGY

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

Minimally invasive excision of gynaecomastia – a novel and effective surgical technique

(2010) O Qutob et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

Gynecomastia in prepubertal and pubertal men

(2009) Nina S Ma et al.   CURRENT OPINION IN PEDIATRICS

An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients

(2009) Davide Bedognetti et al.   EUROPEAN UROLOGY

Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target

(2009) Yu Chen et al.   LANCET ONCOLOGY

Drug-induced gynecomastia

(2008) Ari Eckman et al.   Expert Opinion On Drug Safety